ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

Clinical trial NCT05507203 · COMPLETED

Trial details

NCT number: NCT05507203
Sponsor: Abivax S.A.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2022-10-10
Primary completion: 2025-06-24
Enrollment: 639

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.